# Episodic Severe Ectopic Adrenocorticotropic Hormone Syndrome by Metastatic Appendiceal Neuroendocrine Tumor

**Authors:** Ruchi Desai, F N U Sidra, Liwei Jia, Patricio M Polanco, Salwan Al Mutar, Oksana Hamidi

PMC · DOI: 10.1210/jcemcr/luaf171 · JCEM Case Reports · 2025-08-01

## TL;DR

A rare case of severe Cushing syndrome caused by an appendiceal tumor is managed through adrenalectomy and ongoing treatment.

## Contribution

Presents a rare case of metastatic appendiceal neuroendocrine tumor causing episodic Cushing syndrome and its successful management.

## Key findings

- Bilateral adrenalectomy effectively controlled severe hypercortisolism.
- Combination therapy stabilized metastatic appendiceal neuroendocrine tumor.
- Long-term active surveillance with lanreotide maintained disease stability.

## Abstract

Episodic severe Cushing syndrome resulting from ectopic ACTH secretion (EAS) from appendiceal neuroendocrine tumor (NET) is extremely rare. Here, we describe a case of a 24-year-old woman with episodic severe EAS resulting from appendiceal NET with extensive metastatic disease. The patient presented with rapid weight gain, violaceous striae, fatigue, edema, and anxiety. Biochemical evaluation showed markedly elevated 24-hour urinary free cortisol greater than 10-fold above the upper limit of normal, and widely fluctuating peaks and troughs of serum cortisol and ACTH concentrations indicating episodic severe EAS. Surgery for primary malignancy was initially deferred because of the high risk of perioperative complications related to severe hypercortisolism. She underwent bilateral adrenalectomy as first-line definitive treatment for severe EAS. Four months after adrenalectomy, she underwent cytoreductive surgery for primary metastatic appendiceal NET. Subsequent peptide receptor radionuclide therapy and monthly lanreotide injections rendered her disease stable. Three years after the initial presentation, she continued to undergo active surveillance with maintenance lanreotide for residual but stable metastatic appendiceal neuroendocrine tumor. This case of a rare metastatic appendiceal NET with EAS demonstrates the importance of individualized management and highlights the need for consideration of prompt bilateral adrenalectomy for patients with severe Cushing syndrome.

## Linked entities

- **Diseases:** Cushing syndrome (MONDO:0018912), neuroendocrine tumor (MONDO:0019496)

## Full-text entities

- **Genes:** POMC (proopiomelanocortin) [NCBI Gene 5443] {aka ACTH, CLIP, LPH, MSH, NPP, OBAIRH}, SYP (synaptophysin) [NCBI Gene 6855] {aka MRX96, MRXSYP, XLID96}
- **Diseases:** fatigue (MESH:D005221), insomnia (MESH:D007319), islet cell tumors (MESH:D007516), hypokalemia (MESH:D007008), Cancer (MESH:D009369), pheochromocytoma (MESH:D010673), weight gain (MESH:D015430), anxiety (MESH:D001007), appendiceal mass (MESH:D001063), adrenal insufficiency (MESH:D000309), Cushing syndrome (MESH:D003480), thymic NET (MESH:D013953), metastases (MESH:D009362), hirsutism (MESH:D006628), weakness (MESH:D018908), Appendiceal Neuroendocrine Tumor (MESH:D018358), parasomnia (MESH:D020447), medullary thyroid carcinoma (MESH:C536914), Rare Diseases (MESH:D035583), acne (MESH:D000152), hepatic mass (MESH:C536030), edema (MESH:D004487), diabetes mellitus (MESH:D003920), Adrenocorticotropic Hormone Syndrome (MESH:C535668), small cell lung cancer (MESH:D055752), EAS (MESH:D000182), palpitations (MESH:D006331), metastatic disease (MESH:D000092182)
- **Chemicals:** DOTA-Tyr3-octreotate (-), Ga-68 (MESH:C000615430), dexamethasone (MESH:D003907), ketoconazole (MESH:D007654), cortisol (MESH:D006854), potassium (MESH:D011188)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12315537/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12315537/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC12315537/full.md

---
Source: https://tomesphere.com/paper/PMC12315537